Showing results (1521-1530 of 1,565) with videos related to

Sort By:
Pageof 157
Annals of Surgical Oncology|November 20, 2016
The Effect on Surgical Complications of Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer: NRG Oncology/NSABP Protocol B-40Harry D Bear, Gong Tang, Priya Rastogi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2023
Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in RhabdomyosarcomaSrivandana Akshintala, R Taylor Sundby, Donna Bernstein, et al.
American Journal of Medical Genetics. Part A|January 9, 2020
Advancing RAS/RASopathy therapies: An NCI-sponsored intramural and extramural collaboration for the study of RASopathiesAndrea M Gross, Megan Frone, Karen W Gripp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2017
Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2Patricia A Ganz, Edward H Romond, Reena S Cecchini, et al.
Nature Medicine|February 3, 2025
Bioaccumulation of microplastics in decedent human brainsAlexander J Nihart, Marcus A Garcia, Eliane El Hayek, et al.
BMC Pregnancy and Childbirth|March 7, 2020
OptiBIRTH: a cluster randomised trial of a complex intervention to increase vaginal birth after caesarean sectionMike Clarke, Declan Devane, Mechthild M Gross, et al.
The American Journal of Surgical Pathology|March 2, 2026
Does This Imaging Make Me Look NFATC2? The Value of Radiologic-pathologic Correlation in NFATC2-rearranged Sarcomas of BoneMichael E Kallen, Raul Perret, Gregory W Charville, et al.
The Journal of Biological Chemistry|April 23, 2010
Kinetic approach to pathway attenuation using XOMA 052, a regulatory therapeutic antibody that modulates interleukin-1beta activityMarina K Roell, Hassan Issafras, Robert J Bauer, et al.
Diabetes|March 10, 2012
A fully human, allosteric monoclonal antibody that activates the insulin receptor and improves glycemic controlVinay Bhaskar, Ira D Goldfine, Daniel H Bedinger, et al.
Virchows Archiv : an International Journal of Pathology|December 6, 2024
YAP1::KMT2A-rearranged sarcomas harbor a unique methylation profile and are distinct from sclerosing epithelioid fibrosarcoma and low-grade fibromyxoid sarcomaLaura M Warmke, Baptiste Ameline, Karen J Fritchie, et al.
Pageof 157